MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
571.40%
Quick Ratio
571.40%
Cash Ratio
108.78%
Debt to Asset Ratio
19.49%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total current assets
    • Operating lease right-of-use ass...
    • Restricted cash
    • Property and equipment, net
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
23,370
25,661
28,492
26,983
Investments
94,571
112,558
134,777
76,999
Restricted cash
0
385
670
285
Prepaid expenses and other current assets
4,812
4,962
3,015
3,304
Total current assets
122,753
143,566
166,954
107,571
Restricted cash
385
-
0
385
Property and equipment, gross
4,477
4,471
4,465
4,458
Less accumulated depreciation
4,406
4,355
4,306
4,257
Property and equipment, net
71
116
159
201
Operating lease right-of-use assets
3,779
798
1,082
1,357
Total assets
126,988
144,480
168,195
109,514
Accounts payable
5,254
435
2,215
2,740
Accrued expenses
15,230
16,498
16,844
12,578
Operating lease liabilities
999
1,205
1,633
1,742
Total current liabilities
21,483
18,138
20,692
17,060
Operating lease liabilities, noncurrent
3,265
-
0
307
Total liabilities
24,748
18,138
20,692
17,367
Common stock, 0.0001 par value 300,000,000 shares authorized, 18,671,498 and 17,611,511 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
2
2
2
1
Additional paid-in capital
715,781
704,900
702,984
627,024
Accumulated deficit
-613,436
-578,399
-555,430
-534,875
Accumulated other comprehensive loss
-107
-161
-53
-3
Total stockholders equity
102,240
126,342
147,503
92,147
Total liabilities and stockholders equity
126,988
144,480
168,195
109,514
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$94,571K (-2.05%↓ Y/Y)Cash and cashequivalents$23,370K (16.59%↑ Y/Y)Prepaid expenses andother current assets$4,812K (-19.10%↓ Y/Y)Property and equipment,gross$4,477K (0.43%↑ Y/Y)Total current assets$122,753K (-0.06%↓ Y/Y)Operating leaseright-of-use assets$3,779K (132.70%↑ Y/Y)Restricted cash$385K (0.00%↑ Y/Y)Property and equipment,net$71K (-71.71%↓ Y/Y)Less accumulateddepreciation$4,406K (4.73%↑ Y/Y)Total assets$126,988K (1.52%↑ Y/Y)Total liabilities andstockholders equity$126,988K (1.52%↑ Y/Y)Total stockholdersequity$102,240K (-7.88%↓ Y/Y)Total liabilities$24,748K (75.59%↑ Y/Y)Accumulated deficit-$613,436K (-19.92%↓ Y/Y)Accumulated othercomprehensive loss-$107K (-174.36%↓ Y/Y)Additional paid-in capital$715,781K (14.97%↑ Y/Y)Total currentliabilities$21,483K (61.13%↑ Y/Y)Operating leaseliabilities, noncurrent$3,265K (329.04%↑ Y/Y)Common stock, 0.0001par value...$2K (100.00%↑ Y/Y)Accrued expenses$15,230K (99.08%↑ Y/Y)Accounts payable$5,254K (31.75%↑ Y/Y)Operating leaseliabilities$999K (-41.06%↓ Y/Y)

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. (CRBP)